Bioanalytical Testing Services Market Revenue Share Detailed Analysis Report 2022-2031

Bioanalytical Testing Services Market Outlook 2031

• The global bioanalytical testing services
market was valued at US$ 2.11 Bn in 2021

• The global market is projected to advance at a CAGR of 15.7% from 2022 to 2031

• The global bioanalytical testing services market is anticipated to reach more than US$ 8.95 Bn by 2031

Get Sample of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=45450

Bioanalytical Testing Services Market Trends
Rise in demand for biopharma products and increase in need to develop novel bioanalytical assay platforms are the key factors driving investments in bioanalytical R&D and laboratories. Increase in trend of outsourcing laboratory testing services for quality check has encouraged companies to offer various types of services and solutions in the market.

This is anticipated to propel the bioanalytical testing services market. Growth in merger and acquisition activities across the globe is also augmenting the demand for bioanalytical assay services. For instance, in October 2021, BioAgilytix signed an agreement to acquire Australia-based 360biolabs.

COVID-19 Impact on Bioanalytical Testing Services Market

Bioanalytical diagnostic technologies play a crucial role in containing the COVID-19 pandemic. They are likely to help contain the future waves of the pandemic and infectious disease outbreaks. In the event of a major pandemic such as COVID-19, a combination of different diagnostic technologies (centralized and point-of-care, and reliance on multiple biomarkers) is required for effective diagnosis, treatment selection, prognosis, patient monitoring, and epidemiological surveillance. Several biotech and pharmaceutical companies have been focusing on developing effective technologies for rapid diagnosis of COVID-19.

Request Report Methodology@ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=45450

They have been concentrating on developing vaccines/therapeutics that can help mitigate the spread of the disease by ensuring appropriateness of care across all healthcare settings and achieving high-quality outcomes. This is driving the demand for bioanalytical assay services across the globe.

For instance, CIRION BioPharma Research, Inc., a GLP-certified contract research laboratory based in the U.S., announced in July 2020 that it was expanding its bioanalytical testing services to support COVID-19 drug and vaccine development.
Increase in Usage of Immunogenicity and Immune-based Therapy to Propel Immunology Segment
Immunogenicity testing is required throughout the development process to assess the immune response in preclinical models using clinical samples. Immunogenicity testing examines antibodies created against a treatment.

It helps establish efficacy and safety with assurance in vaccine and biologics production or gene therapy. Hence, immunology bioanalytical tests are crucial in the clinical phase for practically all modern medicines, from monoclonal antibodies (mAbs) for oncology to vaccine programs and gene & cell therapies. Any therapy that provokes an immune response requires clinical immunological testing to ensure that the response does not jeopardize patient safety.

In terms of application, immunology is likely to be the fastest growing segment of the global market during the forecast period.

Therefore, increase in usage of immunogenicity and immune-based therapy is projected to boost the immunology segment during the forecast period.

Read Report Overview@ https://www.transparencymarketresearch.com/bioanalytical-testing-services-market.html

Rise in R&D Investment Augmenting Mass Spectroscopy Segment

The mass spectrometry segment is projected to account for major share of the global bioanalytical testing services market by 2031. R&D spending by pharmaceutical companies has increased significantly in the last two decades.

Biopharmaceutical research is supported by investments in specialties such as biopharma and precision medicine. The study of large molecules is currently a hot topic of discussion in the bioanalytical community.

Growing importance of peptides and proteins as therapeutic agents, combined with the significant opportunities provided by new MS-based technology, has opened up a whole new world for bioanalytical scientists. Rise in usage of mass spectrometers in pharmaceutical and biopharmaceutical industries and adoption of new applications in the bioanalytical testing services market are the key factors driving the mass spectroscopy segment.

Surge in Specialized Testing Services to Boost Biotech & Pharmaceuticals Companies Segment
Based on end-user, the biotech & pharmaceutical companies segment is projected to advance at a CAGR of 15.1% during the forecast period. Biotech and pharmaceutical companies are focusing on specialized testing services including gene expression analysis, liquid chromatography-mass spectrometry (LC/MS), raw material wet chemistry analysis, and metal analysis with inductive mass spectrometry (ICP-MS).

Furthermore, pharmaceutical companies are increasing outsourcing of early-phase development, clinical, and laboratory testing services to boost revenue, avoid high capital spending, and decrease the time taken to validate processes and products.

Get Customization Research on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=45450

Regional Outlook of Global Bioanalytical Testing Services Market

North America is projected to be a highly attractive region of the global market during the forecast period. The region accounted for more than 45% share of the global market in 2021 due to the presence of large number of patients with various chronic diseases and rise in adoption of peptides and other large molecule therapeutics.

According to the Centers for Disease Control and Prevention, more than 877,500 people in the U.S. succumb to heart disease or stroke every year (i.e., one-third of all deaths). These diseases take an economic toll, costing the health care system US$ 216 Bn per year.

Europe was the second largest bioanalytical testing services market in terms of revenue in 2021. High share of the region can be ascribed to the increase in investment in biotechnology and pharmaceutical R&D activities.

Furthermore, rise in in cases of chronic diseases is driving the market in Europe. For instance, cardiovascular disease (CVD) accounted for 3.9 million deaths in Europe in 2017. Around 15% of CVD deaths in the region are due to high blood sugar. Prevalence of diabetes in the region is high. It has increased rapidly in the past 10 years, rising by more than 50% in several countries in the region. Hence, increase in incidence of diseases is propelling the market in Europe.

Make an Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=45450

The market in Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period. Increase in clinical trial activities in emerging markets is primarily ascribed to factors such as cost savings, large treatment-naive population, retention of clinical trial participants, and constantly improving regulatory procedures.

Furthermore, China's bioanalytical testing services have increased due to the growth in drug innovation and development activities in the last decade. This is expected to drive the market in the country during the forecast period.

Analysis of Key Players in Global Bioanalytical Testing Services Market

This report includes vital information about the key players operating in the global bioanalytical testing services market. Companies are focusing on strategies such as new product launches, divestiture, mergers & acquisitions (M&A), and partnerships to strengthen their position in the market. Charles River Laboratories International, Inc., Bioreliance Corporation, Intertek Group plc, Eurofins Scientific SE, BioclinResearch Laboratories, Labcorp, Wuxi AppTec, Envigo, BioAgilytix Labs, Syneos Health, and Frontage Labs are the prominent players operating in the global bioanalytical testing services market.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.